Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management Dysgeusia (taste disturbance) is not listed in the UK Summary of Product Characteristics for Ozempic Potential contributing factors include gastrointestinal side effects, dehydration, concurrent medications, vitamin B12 deficiency, or oral health issues Management includes good oral hygiene, dietary modifications, staying hydrated, and reviewing concurrent medications with your healthcare provider Contact your GP if metallic taste persists beyond 23 weeks, affects nutritional intake, or accompanies other concerning symptoms Alternative diabetes medications include other GLP-1 agonists, SGLT2 inhibitors, DPP-4 inhibitors, or insulin therapy as recommended by NICE guidance Table of Contents What Causes Metallic Taste When Taking Ozempic
While clinical studies on the efficacy of GLP-1 patches are not yet available, some patients using commercially available patches report reduced food noise and decreased hunger
The company is positioning microdosing as the easiest way to start a GLP-1, with promises of fewer side effects and lowest effective dose claims
Mangels et al., 2016)
Multivitamins provide the foundational nutrients your skin needs, while fish oil delivers targeted anti-inflammatory benefits
2021, 2022a, 2022b)
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
